ADVANCED MALIGNANT TUMORS
Clinical trials for ADVANCED MALIGNANT TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody cocktail targets tough tumors
Disease control OngoingThis study tests two experimental drugs (AK112 and AK117) given together to people with advanced solid tumors that have not responded to other treatments. The goal is to see if the combination is safe and can shrink or control the tumors. About 154 adults aged 18 to 75 are taking…
Matched conditions: ADVANCED MALIGNANT TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Akeso • Aim: Disease control
Last updated May 17, 2026 13:58 UTC
-
New drug combo targets Hard-to-Treat cancers
Disease control OngoingThis early-stage study tests an experimental drug, BMS-986488, alone or with other treatments, in adults with advanced solid tumors that have not responded to standard therapy. The main goals are to check safety and find the right dose. About 437 participants with specific cancer…
Matched conditions: ADVANCED MALIGNANT TUMORS
Phase: PHASE1 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 17, 2026 13:53 UTC
-
New cancer drug SG2918 enters first human safety trial
Disease control OngoingThis early-stage study tests a new drug called SG2918 in 17 people with advanced cancers that have not responded to standard treatments. The main goal is to check if the drug is safe and tolerable, and to see early signs of whether it can help control the disease. Participants re…
Matched conditions: ADVANCED MALIGNANT TUMORS
Phase: PHASE1 • Sponsor: Hangzhou Sumgen Biotech Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 13:53 UTC